Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EW-2: High-dose therapy for metastatic Ewing sarcoma
NCT02727387Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Jun 2009
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib, cyclophosphamide in Ewing sarcoma, sponsored by Italian Sarcoma Group. Started Jun 2009; status: completed.
02
Drugs
celecoxibcyclophosphamide
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT02727387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02727387.